How to Build the Board Business Case for Owning Your AI

A board approves on-premise AI on four numbers, not on a feature list. The subscription spend it replaces, the compliance evidence it produces by design, the third-party concentration risk it removes, and the asset the organisation holds rather than a cost it keeps renting. Put those four figures on a single page, in the board's own language, and the decision largely makes itself.

The mistake most proposals make is leading with the technology. A board does not buy inference engines, model weights, or context windows. It approves a change in where value sits, who carries the risk, and what the organisation owns at the end of the year. Everything technical is evidence in service of those four numbers. This is the decision paper we would put in front of directors, and the arithmetic each line rests on.

The one-page decision paper

Four lines, each a number your finance and risk functions can already produce or estimate:

• Subscription spend replaced. The recurring per-seat and per-token fees you stop paying once inference runs on hardware you own.
• Compliance evidence produced by design. The audit, attestation and assurance work that comes out of the system automatically, rather than being commissioned separately.
• Third-party concentration risk removed. The exposure you retire when your most sensitive workloads no longer depend on a single external provider's availability, pricing and policy.
• The asset you hold, not the cost you rent. The owned capability that sits on the balance sheet at year end, versus an operating expense that renews forever and returns nothing.

The rest of this article is the working behind each line.

Number one: the subscription spend you stop renting

Start with the figure the board already recognises. Rented AI is billed per seat and per unit of usage, and both rise with adoption. The more useful the tool becomes, the more it costs, and the bill never converges. Model the current annual run rate, then project it forward on your actual adoption curve rather than today's pilot volume. That forward line is the number you are proposing to replace.

Owning the inference changes the shape of the spend. You buy hardware once, you run it, and marginal usage is close to free because you are not metered on your own machine. The honest comparison is not one month against another. It is the multi-year rented curve, which keeps climbing, against an owned cost that is largely fixed after the initial outlay. Boards understand a crossover point. Show them where the two lines cross and how much of the rented curve sits above it.

Number two: the compliance evidence produced by design

In a regulated organisation, proving what a system did is a cost centre in its own right: logging, evidence-gathering, external assurance, and the audit time spent reconstructing after the fact. When AI touches customer data, clinical records, financial decisions or anything a regulator can ask about, that evidence burden grows with every use.

The board number here is the assurance work you no longer have to commission because the architecture produces the evidence itself. On-premise AI that seals every action to a tamper-evident record turns audit from an investigation into a lookup. When someone entitled to ask wants to know which model ran, on which machine, for a given action, the answer is a signed record rather than a reconstruction. Quantify it as the audit and assurance hours removed, plus the regulatory risk you are no longer carrying uninsured. Evidence generated as a by-product of normal operation is cheaper than evidence assembled under deadline.

Number three: the concentration risk you remove

Every director understands single points of failure. Routing your most sensitive workloads through one external AI provider is exactly that, and it is a risk the board is accountable for whether or not it has been named. The provider sets the price, controls availability, changes terms, deprecates models you depend on, and holds your data as the condition of service. None of that is under your control, and all of it can change without your consent.

Owning the capability retires that exposure. The number is the value of removing a dependency your business continuity, procurement and risk functions would otherwise have to mitigate around. Frame it the way the board already frames supplier concentration in any other category: what happens to operations, cost and reputation if the single provider changes the deal, and what it is worth to make that question irrelevant. Sovereignty is not a slogan here. It is the removal of a named risk from the register.

Number four: the asset you hold, not the cost you rent

The final line is the one that changes the character of the whole proposal. A subscription is an operating cost that renews forever and leaves you owning nothing. An on-premise capability is an asset: hardware you hold, a licence you control, and an accumulating base of governed work and institutional knowledge that stays inside the building.

For the board this is the difference between spending and investing. At the end of the year the rented option has produced a stack of invoices. The owned option has produced a capability the organisation controls, on infrastructure it holds, generating its own compliance evidence as it runs. Put both on the page and let directors see which one they would rather have on the balance sheet.

Arrange it as one page, in the board's language

Keep the paper to a single page. Four numbers across the top, each with one line of working beneath it, and one closing sentence that states the decision plainly: whether to keep renting an escalating cost that leaves you owning nothing and dependent on one supplier, or to own the capability, remove the risk, and generate your compliance evidence by design. Everything technical belongs in an appendix. The board approves the four numbers. The appendix is where the engineering earns them.

Where Mickai fits

Mickai is the Sovereign Intelligence Operating System (SIOS), enterprise AI built to run offline on hardware the organisation owns. It runs on Poros, our sovereign inference engine, so a capable model runs locally with nothing leaving the building. Every action is sealed under post-quantum cryptography to an Offline Attestation Record (OAR): tamper-evident, independently verifiable offline, and designed so silent alteration shows. That architecture is what turns each of the four board numbers from an aspiration into evidence. Local inference replaces the subscription; the OAR produces the compliance evidence by design; running on your own hardware removes the concentration risk; and the result is a capability you own.

The approach is protected by 104 filed UK patent applications carrying 2,340 claims, under named inventor Micky Irons. MICKAI is a registered UK trademark, and the operating system is built and held by Mickai LTD (Companies House 17166618). We patent the enforcement mechanism, not the model: how sovereignty, auditability and licensing are enforced, which is precisely the terrain a board is approving when it decides to own its AI rather than rent it.

Frequently asked questions

What is the business case for on-premise AI in one sentence?

Owning your AI replaces an escalating subscription cost with a capability you hold, produces the compliance evidence you need as a by-product of running, and removes the risk of routing your most sensitive work through a single external provider. The board approves it on those outcomes, not on the underlying technology.

What four numbers does a board actually need to approve on-premise AI?

Four: the subscription spend replaced, the compliance evidence produced by design, the third-party concentration risk removed, and the asset you hold rather than a cost you keep renting. Put each on one line with its working beneath it, and the four figures are the decision. Everything else is supporting evidence in an appendix.

Is owning AI cheaper than a cloud subscription?

Compared over multiple years rather than a single month, owned inference is fixed after the initial hardware outlay while a subscription keeps climbing with adoption and usage. The honest comparison is the rising rented curve against the largely flat owned cost, and the crossover point where owning becomes the cheaper option. The heavier and more sensitive your usage, the sooner that point arrives.

How does on-premise AI reduce compliance cost?

When every action is sealed to a tamper-evident, independently verifiable record, audit becomes a lookup rather than an investigation. The evidence a regulator or auditor asks for is generated automatically as the system runs, which removes the assurance work you would otherwise commission separately and reduces the regulatory risk you carry uninsured.

What is third-party concentration risk and why does the board care?

It is the exposure created when critical or sensitive workloads depend on a single external provider that controls pricing, availability, terms and access to your data. The board is accountable for single points of failure in any supplier category, and AI is no exception. Owning the capability retires that dependency and takes the named risk off the register.

How does Mickai support the board decision?

Mickai runs capable AI offline on hardware you own, on our Poros inference engine, with every action sealed to the Offline Attestation Record, which is tamper-evident and verifiable without a network. That design maps directly onto the four board numbers: it replaces the subscription, produces compliance evidence by design, removes the concentration risk, and leaves you owning the capability. The approach is covered by 104 filed UK patent applications carrying 2,340 claims.